key: cord-0766227-w96gf5s9
authors: Stronach, Benjamin M.; Zhang, Xiaoran; Haas, Derek; Iorio, Richard; Anoushiravani, Afshin; Barnes, C. Lowry
title: Worsening Arthroplasty Utilization with Widening Racial Variance During the COVID-19 Pandemic
date: 2022-03-09
journal: J Arthroplasty
DOI: 10.1016/j.arth.2022.03.001
sha: da9ce1264aa432f03c79ba60adc68b02ae030678
doc_id: 766227
cord_uid: w96gf5s9

INTRODUCTION: Elective arthroplasty surgery in the United States came to a near-complete halt in the spring of 2019 as a response to the COVID-19 pandemic. Racial disparity has been a long-term concern in healthcare with increased focus during the pandemic. The purpose of this study is to evaluate the effects of COVID-19 and race on arthroplasty utilization trends during the pandemic. METHODS: We used 2019 and 2020 Center for Medicare and Medicaid Service (CMS) fee-for-service (FFS) claims data to compare arthroplasty volumes prior to and during the COVID-19 pandemic. We compared overall arthroplasty utilization rates between 2019 and 2020 and then sought to determine the effect of race and COVID-19, both independently and combined. RESULTS: There was a decrease in primary TKA (-28%), primary THA (-14%), primary THA for fracture (-2%) and revision arthroplasty (-14%) utilization between 2019 and 2020. The highest decrease in overall arthroplasty utilization was in the Hispanic population (34% decrease versus 19% decrease in White population). We found that a non-White patient was 39.9% (p < 0.001) less likely to receive a TJA prior to COVID-19. The COVID-19 pandemic further exacerbated the pre-existing racial differences in arthroplasty utilization by decreasing the probability of receiving a TJA for non-white patient by another 12.9% (p < 0.001). CONCLUSION: We found an overall decreased utilization rate of arthroplasty during the COVID-19 pandemic with further decrease noted in all non-White populations. This raises significant concern for worsening racial disparity in arthroplasty caused by the ongoing pandemic.

Elective arthroplasty surgery in the United States came to a near-complete halt in the spring of 6 2019 as a response to the COVID-19 pandemic. Racial disparity has been a long-term concern in 7 healthcare with increased focus during the pandemic. The purpose of this study is to evaluate 8 the effects of COVID-19 and race on arthroplasty utilization trends during the pandemic. 9

We used 2019 and 2020 Center for Medicare and Medicaid Service (CMS) fee-for-service (FFS) 11 claims data to compare arthroplasty volumes prior to and during the COVID-19 pandemic. We 12 compared overall arthroplasty utilization rates between 2019 and 2020 and then sought to 13 determine the effect of race and COVID-19, both independently and combined. 14

There was a decrease in primary TKA (-28%), primary THA (-14%), primary THA for fracture (-16 2%) and revision arthroplasty (-14%) utilization between 2019 and 2020. The highest decrease 17 in overall arthroplasty utilization was in the Hispanic population (34% decrease versus 19% 18 decrease in White population). We found that a non-White patient was 39.9% (p < 0.001) less 19 likely to receive a TJA prior to COVID-19. The COVID-19 pandemic further exacerbated the pre-20 existing racial differences in arthroplasty utilization by decreasing the probability of receiving a 21 TJA for non-white patient by another 12.9% (p < 0.001). The SARS-CoV-2 (COVID-19) pandemic caused a significant disruption in the volume of 30 elective surgeries as the virus spread globally in the winter and spring of 2020. We previously 31 reported a 94% reduction in total knee arthroplasty (TKA) volume and 92% reduction in total 32 hip arthroplasty volume (THA) identified hip and knee procedures through each case's primary international classification of 78 diseases 10 th revision procedure (ICD-10-PCS) codes. We also identified if a case was a hip 79 fracture through its primary ICD-10 diagnosis code. We then divided our data into the following 80 groups: primary TKAs, primary non-fracture THAs, primary fracture THAs, and combined 81 revision arthroplasty of hip or knee. 82 83

We defined race and ethnicity using the race variable from the Medicare beneficiary 85 enrollment data. Race and ethnicities include White, Black, Hispanic, Asian, other, and 86 unknown. We grouped Black, Hispanic, Asian, and other into the non-White racial group to 87 compare with the White racial group. We also separately compared Black, Asian, Hispanic, and 88 other non-White groups to the White patient group. Figure 1 ). We found that the most 118 recently available 2020 TJA utilization rates across all procedure types has not returned to the 119 baseline rates reported prior to the COVID-19 pandemic (Figure 1 and 2) . 120

The decreased utilization of arthroplasty during the COVID-19 pandemic was noted 121 across all racial groups but was more pronounced in all non-White populations when compared 122 to the White population for each arthroplasty type evaluated. (Table 2) . 141

By studying the interaction between COVID-19 and non-White racial groups, we were 142 able to quantify the differential effect of the COVID-19 pandemic on each non-White 143 population. The effect of COVID-19 on the pooled non-White racial group was -12.9% (95% CI [-144 14.5%, -11.3%], p < 0.001), meaning that with the TJA volume decreasing for both populations, (Table 3) . 160

The impact of COVID-19, with the resultant moratorium placed on elective procedures 163 in the United States, had an immediate and dramatic effect on arthroplasty surgery. Bedard and 164 coworkers estimated 30,000 primary hip and knee arthroplasty cancellations on a weekly basis 165 due to the restrictions that were imposed during the elective surgery moratorium [21]. We 166 have found that arthroplasty utilization significantly improved with the return to elective 167 surgery, but there has been a sustained decrease in surgical volume that has persisted 168 throughout the COVID-19 pandemic that has not yet returned to pre-pandemic utilization rates. 169

The COVID-19 pandemic has also been disruptive for patients in need of arthroplasty 170 due to social and psychological factors beyond the physical limitations from surgical 171 restrictions. The uncertainty of not knowing when their surgical procedure would be 172 rescheduled was the highest source of anxiety for patients awaiting surgery. This caused more 173 anxiety than financial issues, the risk of contracting COVID-19 and concerns of job security. An 174 overwhelming majority of patients (90%) in this survey wished to reschedule surgery as soon as 175 permitted [8] . Despite this, we found that patients have not yet returned to pre-pandemic 176 surgical utilization levels which is likely a multifactorial issue. 177

We found a decreased utilization of all arthroplastyprocedure types prior to the 178 pandemic in all non-White patient groups when compared to the White population (Table 2) . 179

Racial disparity has been well documented in decreased arthroplasty utilization of non-White 180 groups prior to the COVID-19 pandemic [15] [16] [17] [18] and our results are consistent with these 181 findings. We then determined the exacerbation of this effect based on procedure type when 182 comparing White patients to non-White patient groups during the pandemic (Table 3) . We 183 found an exacerbation in decreased utilization of TKA for all non-White racial groups with a 184 worsening in THA utilization for Black and Hispanic patients but not Asian and other non-White 185 patients and exacerbation effect for revision TJA in black patients only. However, there was no 186 exacerbation effect seen in THA for fracture in all non-White groups or in revision arthroplasty 187

for Hispanic, Asian and other non-Whites. This suggests a worsening of racial disparity due to 188 the current COVID-19 pandemic as there is worsening utilization in the procedure groups that 189 are considered elective but procedures that are typically more urgent in nature, such as THA for 190 fracture, had similar decreased utilization rates when comparing White to non-White groups. 191

The cause for racial disparity is multifactorial and includes socioeconomic factors, 192 discriminatory healthcare practices, geographic, and cultural differences in seeking care [14] . 193 Racial disparity has also been identified as an ongoing issue of concern in the Black population 194 due to the pandemic with increased morbidity and mortality noted from COVID-19 in this 195 patient population [19, 20] . This racial effect appears to have also affected the arthroplasty 196 community as we found a worsening surgical utilization in all non-White racial groups during 197 the COVID pandemic with a slower return to arthroplasty surgery as elective procedures were 198 resumed. 199

The racial differences reported from this study and others during the pandemic does not There are limitations to this study. This was based on Medicare data and does not 210 include patients that do not have Medicare insurance and so may not adequately reflect the 211 arthroplasty volume trends throughout the population in the United States. We have made 212 significant efforts to minimize any confounding effects on the results with our statistical 213 analysis, but this study provides trends due to the use of a retrospective database and does not 214 allow for proof of causation in regards to the effect of the COVID-19 pandemic on arthroplasty 215

volume. This analysis also found a clear relationship between patient race and arthroplasty 216 utilization among the non-White population but this does not explicitly demonstrate a racial 217 disparity as we cannot provide the underlying cause(s) for our findings based on the available 218 data. Despite this, we have made significant efforts to control for confounding factors which 219 may be responsible for racial effect. 220

The determination of causation will require an extensive analysis of potential 221 contributing factors, such as geographic location, state-based COVID restrictions, regional 222 population density and COVID vaccination rates, to determine if our findings are due to ongoing 223 racial disparity. The intent of this research was to first establish if the COVID pandemic has 224 impacted arthroplasty utilization based on race. We have been able to confirm this and further 225 work is now required to determine the underlying cause(s) for these findings. 226

The utilization of arthroplasty procedures in the United States Medicare population has 229 improved with the resumption of elective surgery but has not returned to pre-COVID levels. 230

There has been an overall 20% decrease in arthroplasty utilization when comparing pre-COVID 231 utilization to the same period in 2020 following the restart of elective surgery. Our results 232 identified decreased arthroplasty utilization in all non-White populations prior to COVID-19 that 233 has been further exacerbated due to the pandemic. 234 

the COVID-19 Pandemic

Unequal Treatment: Confronting Racial and Ethnic 280 Disparities in Health Care (with CD)

Persistent Racial Disparities in Utilization Rates

Racial disparities in receiving total hip/knee 284 replacement surgery: The effect of hospital admission sources

Racial disparities 287 in lower extremity arthroplasty outcomes and use

Racial disparities in joint replacement use 290 among older adults

COVID-19 and Racial/Ethnic Disparities

Hospitalization and Mortality among Black 296 Patients and White Patients with Covid-19

Effect of COVID-19 on Hip and Knee Arthroplasty Surgical 299 Volume in the United States

Latest Data on COVID-19 Vaccinations by Race/Ethnicity

Kaiser Family Foundation

Demographic Characteristics of People 305

Receiving COVID-19 Vaccinations in the United States